These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9652570)

  • 1. Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Mueller KH; Brom J; Ross R; von Essen R; Tebbe U
    Lancet; 1997 Oct; 350(9086):1225. PubMed ID: 9652570
    [No Abstract]   [Full Text] [Related]  

  • 2. Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Carlsson J; Miketic S; Brom J; Ross R; Bachmann H; Tebbe U
    Int J Cardiol; 2000 Apr; 73(2):165-71. PubMed ID: 10817856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease.
    Stiegler H; Kolbe-Busch S; Fischer Y; Leschke M; Reinauer H
    Lancet; 1998 Jan; 351(9096):143. PubMed ID: 9439521
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease.
    Taylor-Robinson D; Thomas BJ
    Lancet; 1998 Jan; 351(9096):142; author reply 143. PubMed ID: 9439520
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of restenosis following percutaneous transluminal coronary angioplasty: an important but elusive goal.
    Buffon A; Maseri A
    Am J Cardiol; 1998 Sep; 82(6):836-7. PubMed ID: 9761106
    [No Abstract]   [Full Text] [Related]  

  • 6. Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.
    Hayashida K; Tanaka M; Morita H; Hayashi F; Inada T; Suzuki H; Sakamoto T; Katsuragawa M; Hibino H; Kambara H
    Heart Vessels; 2002 May; 16(4):137-45. PubMed ID: 12224784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of Chlamydia pneumoniae and cytomegalovirus infections on prevalence and the course of coronary artery disease].
    Kruk M; Przyłuski J; Deptuch TW; Dzielińska Z; Kadziela J; Podsiadły E; Siennicka J; Piotrowski W; Kańtoch M; Tylewska-Wierzbanowska S; Ruzyłło W
    Pol Arch Med Wewn; 2001 Jan; 105(1):39-44. PubMed ID: 11505697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention.
    Rahel BM; Visseren FL; Suttorp MJ; Plokker TH; Kelder JC; de Jongh BM; Diepersloot RJ; Verkooyen RP; Bouter KP
    Am Heart J; 2004 Oct; 148(4):670-5. PubMed ID: 15459599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty.
    Manegold C; Alwazzeh M; Jablonowski H; Adams O; Medve M; Seidlitz B; Heidland U; Häussinger D; Strauer BE; Heintzen MP
    Circulation; 1999 Mar; 99(10):1290-4. PubMed ID: 10077511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].
    Grabczewska Z; Nartowicz E
    Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High anti-cytomegalovirus (CMV) IgG antibody titer is associated with coronary artery disease and may predict post-coronary balloon angioplasty restenosis.
    Blum A; Giladi M; Weinberg M; Kaplan G; Pasternack H; Laniado S; Miller H
    Am J Cardiol; 1998 Apr; 81(7):866-8. PubMed ID: 9555776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation.
    Daus H; Ozbek C; Saage D; Scheller B; Schieffer H; Pfreundschuh M; Gause A
    Cardiology; 1998 Oct; 90(2):83-8. PubMed ID: 9778543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why first degree relatives of coronary artery disease patient's have Chlamydia pneumoniae infection.
    Jha HC; Mittal A
    Int J Cardiol; 2010 Oct; 144(3):e46-7. PubMed ID: 19167109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is coronary artery disease an infectious disease?
    Sumpter MT; Dunn MI
    Chest; 1997 Aug; 112(2):302-3. PubMed ID: 9266857
    [No Abstract]   [Full Text] [Related]  

  • 15. Chlamydia pneumoniae and other risk factors for atherosclerosis.
    Leinonen M
    J Infect Dis; 2000 Jun; 181 Suppl 3():S414-6. PubMed ID: 10839726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?].
    Fudal M; Wilczewski P
    Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and luminal narrowing after coronary angioplasty.
    Mattila KJ; Juvonen JT; Kotamäki MK; Saikku PA
    J Intern Med; 2001 Jul; 250(1):67-71. PubMed ID: 11454144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Chlamydia pneumoniae: an etiologic of coronary heart disease?].
    Podsiadły E; Tylewska-Wierzbanowska S
    Przegl Epidemiol; 1999; 53(3-4):231-43. PubMed ID: 10800561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
    Pieniazek P; Karczewska E; Stepień E; Tracz W; Konturek SJ
    Med Sci Monit; 2001; 7(5):995-1001. PubMed ID: 11535948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease.
    Jantos CA; Nesseler A; Waas W; Baumgärtner W; Tillmanns H; Haberbosch W
    Clin Infect Dis; 1999 May; 28(5):988-92. PubMed ID: 10452622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.